Company profile

ソレイジア・ファーマ株式会社

EDINET
E33044
Securities
4597
Industry
Pharmaceutical
Latest annual securities report
2026-03-24 Annual Securities Report PDF HTML
Latest financial report
2026-08-13 Semiannual Securities Report PDF HTML
Latest filing
—
Compare this company

Industry position

Pharmaceutical

View details
Profitability Below average Current Bottom 40% 5-year trend Improving
Financial strength Above average Based on Equity ratio Current Top 35% 5-year trend Improving
Growth Above average Current Top 45% 5-year trend Deteriorating
Cash generation Average Current Bottom 48% 5-year trend Broadly stable

Latest half-year results

H1 FY2026

2026/01/01 - 2026/06/30

Consolidated · IFRS · Cumulative YTD

For H1 FY2026, revenue was ¥8 million, down 83.7% year over year. Operating income was -¥570 million, down 6.2% year over year. Net income was -¥579 million, down 4.3% year over year.

Revenue ¥8M down 83.7% year over year
Operating income -¥570M down 6.2% year over year
Net income -¥579M down 4.3% year over year
Operating cash flow -¥325M
Free cash flow -¥359M
Total assets ¥1.9B
Total equity ¥1.45B

Half-year trend

Half-year financial trend

H1 values are cumulative year-to-date.

H2 values are calculated when comparable.

Consolidated · IFRS · Cumulative YTD

Mode

Half-year financial data

Annual key financial indicators

FY2025

Consolidated IFRS

Revenue reached ¥429 million, up 35.8% year over year. Operating income was -¥861 million, up 55.9% year over year. Operating margin was -200.7%. Net income was -¥876 million, up 54.9% year over year. ROE was -50.0%; equity ratio was 81.7%; free cash flow was -¥928 million.

Revenue ¥429M up 35.8% year over year
Operating income -¥861M up 55.9% year over year
Net income -¥876M up 54.9% year over year
Total assets¥2.15B
Total equity¥1.75B
Operating cash flow-¥847M
Free cash flow-¥928M

Industry position details

Pharmaceutical

Annual data for the same fiscal year and industry

Comparison sample varies by metric

Profitability Below average

Operating margin Bottom 60% / ROE Bottom 69%

Financial strength Above average
Based on Equity ratio

Equity ratio Top 38%

Growth Above average

Revenue growth Top 15% / 3-year revenue CAGR Bottom 85%

Cash generation Average

Operating cash flow margin Bottom 58% / Free cash flow margin Bottom 58%

Profitability Industry position history Improving
2025 Bottom 20% 2024 Bottom 11% 2023 Bottom 18% 2022 Bottom 11% 2021 Bottom 8%
Financial strength Industry position history Improving
2025 Top 26% 2024 Top 22% 2023 Top 28% 2022 Top 21% 2021 Top 36%
Growth Industry position history Deteriorating
2025 Top 50% 2024 Bottom 11% 2023 Bottom 40% 2022 Top 42% 2021 Top 20%
Cash generation Industry position history Broadly stable
2025 Bottom 22% 2024 Bottom 16% 2023 Bottom 28% 2022 Bottom 14% 2021 Bottom 12%
Profitability Operating margin -200.7% Industry median -155.7% Bottom 60% Comparison sample 20
Profitability ROE -50.0% Industry median -29.2% Bottom 69% Comparison sample 32
Financial strength Equity ratio 81.7% Industry median 71.4% Top 38% Comparison sample 32
Growth Revenue growth +35.8% Industry median -1.5% Top 15% Comparison sample 21
Growth 3-year revenue CAGR -26.8% Industry median -1.0% Bottom 85% Comparison sample 20
Cash generation Operating cash flow margin -197.4% Industry median -157.8% Bottom 58% Comparison sample 21
Cash generation Free cash flow margin -216.3% Industry median -167.1% Bottom 58% Comparison sample 21

Annual financial data

Fiscal year Scope Accounting standard Revenue Operating income Ordinary income Profit before tax Net income Profit attributable to owners of parent Comprehensive income Total assets Total liabilities Net assets Shareholders' equity Equity Equity attributable to owners of parent Equity for ratio Operating cash flow Investing cash flow Financing cash flow Free cash flow Cash and cash equivalents Basic EPS P/E Share price Market cap Book value per share Dividend per share Shares issued Equity ratio Official equity ratio ROE ROA Operating margin Ordinary income margin Net margin Operating cash flow margin Free cash flow margin Dividend payout ratio Revenue YoY Operating income YoY Ordinary income YoY Profit before tax YoY Net income YoY Total assets YoY Equity YoY Operating cash flow YoY Investing cash flow YoY Financing cash flow YoY Free cash flow YoY Cash and cash equivalents YoY EPS YoY Dividend per share YoY Shares issued YoY Employees YoY Average salary YoY Employees Average salary
FY2025 Consolidated IFRS 429000000 -861000000 -876000000 -876000000 -876000000 -862000000 2145000000 1752000000 1752000000 1752000000 -847000000 -81000000 1425000000 -928000000 1387000000 -3.69 263709010 0.8167832168 0.817 -0.5 -0.4083916084 -2.006993007 -2.041958042 -1.9743589744 -2.1631701632 0.3575949367 0.5586878524 0.5532891382 0.5486862442 0.5748898678 0.5155709343 0.1800580833 0.2076271186 0.1016456922 0.565462754 0.6223132037 0.2071332316 -0.0434782609 22
FY2024 Consolidated IFRS 316000000 -1951000000 -1961000000 -1941000000 -1941000000 -1933000000 1362000000 1156000000 1156000000 1156000000 -1033000000 0 1180000000 -1033000000 886000000 -9.77 218458910 0.8487518355 0.849 -1.6790657439 -1.4251101322 -6.1740506329 -6.1424050633 -3.2689873418 -3.2689873418 -0.4878444084 -0.7129060579 -0.727753304 -0.7455035971 -0.3889636608 -0.3834666667 -1.8774373259 3.2909090909 -1.8774373259 0.217032967 -0.4758308157 0.2528187846 -0.0416666667 23
FY2023 Consolidated IFRS 617000000 -1139000000 -1135000000 -1112000000 -1112000000 -1103000000 2229000000 1875000000 1875000000 1875000000 -359000000 0 275000000 -359000000 728000000 -6.62 174373910 0.8411843876 0.841 -0.5930666667 -0.4988784208 -1.8460291734 -1.8022690438 -0.5818476499 -0.5818476499 -0.434981685 0.5388663968 0.5445425361 0.5635792779 -0.2887683472 -0.2956423742 0.8269045323 1.0 -0.8930377285 0.8559390048 -0.0933997509 0.6052474657 0.0354603212 -0.1111111111 24
FY2022 Consolidated IFRS 1092000000 -2470000000 -2492000000 -2548000000 -2548000000 -2543000000 3134000000 2662000000 2662000000 2662000000 -2074000000 -418000000 2571000000 -2492000000 803000000 -16.77 168402310 0.849393746 0.849 -0.9571750563 -0.8130185067 -2.2619047619 -2.3333333333 -1.8992673993 -2.2820512821 0.9534883721 -0.0210830922 -0.0204750205 -0.0282485876 -0.0031806616 0.0289911094 0.161342499 -1.5487804878 6.1218836565 0.0549867273 0.1246498599 0.1192226891 0.2572383347 -0.6493506494 27
FY2021 Consolidated IFRS 559000000 -2419000000 -2442000000 -2478000000 -2478000000 -2461000000 3144000000 2587000000 2587000000 2587000000 -2473000000 -164000000 361000000 -2637000000 714000000 -19.04 133946210 0.8228371501 0.823 -0.9578662543 -0.7881679389 -4.3273703041 -4.4329159213 -4.4239713775 -4.717352415 0.231277533 0.4122934888 0.4128396249 0.3995638478 -0.4555844156 -0.2916210296 0.1133022589 0.0409356725 -0.8026243849 0.1091216216 -0.7591093117 0.4584755404 0.0882750503 0.0 77
FY2020 Consolidated IFRS 454000000 -4116000000 -4159000000 -4127000000 -4127000000 -4129000000 5775000000 3652000000 3652000000 3652000000 -2789000000 -171000000 1829000000 -2960000000 2964000000 -35.16 123081210 0.6323809524 0.632 -1.1300657174 -0.7146320346 -9.0660792952 -9.09030837 -6.1431718062 -6.5198237885 -0.6534351145 -1.3359818388 -1.3144129104 -1.2104981253 -0.2732192298 -0.4720254446 -2.3683574879 0.7673469388 0.1145642901 -0.8937939859 -0.2798833819 -0.9808450704 0.0534546369 0.4807692308 77
FY2019 Consolidated IFRS 1310000000 -1762000000 -1797000000 -1867000000 -1867000000 -1868000000 7946000000 6917000000 6917000000 6917000000 -828000000 -735000000 1641000000 -1563000000 4116000000 -17.75 116835795 0.8705008809 0.87 -0.2699147029 -0.2349609867 -1.3450381679 -1.4251908397 -0.6320610687 -1.193129771 3.1194968553 0.2650306748 0.2291494633 0.0282091097 -0.0239875829 0.6435643564 -1.87109375 -0.4966257669 0.3939511439 0.0173010381 0.3167821401 0.6774193548 52
FY2018 Consolidated IFRS 318000000 -2445000000 -2422000000 -2422000000 -2423000000 7728000000 7087000000 7087000000 -2323000000 -256000000 3260000000 -2579000000 4046000000 -25.98 0.9170548654 0.917 -0.3417525046 -0.3134057971 -7.6163522013 -7.3050314465 -8.1100628931 -0.2259967726 -1.4058212017 -1.4040155596 0.1612161034 0.1414896287 -1.5488427617 0.5234735798 -0.138003521 -0.7803212034 0.2005400353 -1.1225490196 0.4761904762 31
FY2017 Consolidated IFRS 410851000 -1016285000 -1007481000 -1007481000 -1007095000 6655092000 6208554000 6208554000 -911394000 -537221000 3781918000 -1448615000 3370150000 -12.24 0.9329028059 0.933 -0.162273051 -0.1513849846 -2.452180961 -2.2183078537 -3.5258889476 -0.1804599467 -1.0545994149 -1.1235340488 0.7962485779 0.8082457737 -0.9600334632 0.0367809085 113.4968171813 -0.4164280881 2.2436602258 0.3369447454 0.3125 21
FY2016 Consolidated IFRS 501319000 -494639000 -474436000 -474436000 -476333000 3704995000 3433468000 3433468000 -464989000 -557735000 -33618000 -1022724000 1038996000 -18.46 0.9267132614 0.927 -0.1381798228 -0.1280530743 -0.9463754615 -0.9275311728 -2.0400663051 16

Source filings

Select a document type to load the filings list.

Select a filing type to load the list.

Document filter

Select filing types

Choose the filing types to display.

Filing types containing financial data are selected by default.

Source data: Financial Services Agency EDINET / Data organization, aggregation, and metric calculations: bestforever.jp